Clinical & Industry News

New Britain, PA, March 16, 2026 – Thrombolex, Inc., a commercial-stage medical device company advancing a differentiated pharmaco-mechanical lysis (PML) platform for the treatment of pulmonary embolism (PE) and other thromboembolic diseases,...

Scientia's novel access platform is designed to improve navigability through complex anatomy and simplify neurovascular procedures. By enabling faster and more reliable access, these technologies improve procedural efficiency.

Dr. Amish Raval reported that patients receiving the autologous CardiAMP cell therapy under investigation demonstrated positive evidence of decreased pathological left ventricular remodeling over time compared to patients not receiving the...

"The RELIEF-FIH study provides encouraging early evidence on a novel approach to HF congestion management," stated Dr. Alex Rothman. "By targeting the negative physiological cardiorenal loop, the Relief System modulates venous congestion in...

A wound that remains open for longer than a month is classified as chronic. Worldwide, about 12 million people experience chronic wounds each year, including roughly 4.5 million in the United States. Approximately one in five of these...

Limiting sugar consumption during early childhood may reduce the risk of serious heart problems later in life. A study published in The BMJ, based on data from the end of sugar rationing in the United Kingdom in 1953, found that people...

Munich, Germany – Preliminary results from an Italian registry describe the risk profile of women experiencing acute coronary syndromes and provide insights to improve management.1 These findings were presented today at the EAPCI Summit 2026,...